Michail Charakidis

105 Rocklands Drive
Tiwi, NT 0810, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

From exclusion to engagement and enrolment: single institutional experience of recruiting Aboriginal and Torres Strait Islander peoples for a genomic sequencing study.

From exclusion to engagement and enrolment: single institutional experience of recruiting Aboriginal and Torres Strait Islander peoples for a genomic sequencing study.

Journal: Internal medicine journal

Published: April 16, 2026

Genomic Therapy Matching in Rare and Refractory Cancers.

Genomic Therapy Matching in Rare and Refractory Cancers.

Journal: JAMA oncology

Published: March 05, 2026

An unresectable desmoid tumour demonstrating long-term complete response to imatinib monotherapy: a case report.

An unresectable desmoid tumour demonstrating long-term complete response to imatinib monotherapy: a case report.

Journal: Journal of medical case reports

Published: August 12, 2025

A phase II trial of larotrectinib in tumors with NTRK fusions or extremes of NTRK mRNA overexpression identified by comprehensive genomic profiling.

A phase II trial of larotrectinib in tumors with NTRK fusions or extremes of NTRK mRNA overexpression identified by comprehensive genomic profiling.

Journal: The oncologist

Published: August 28, 2024

Improved cancer survival in the Northern Territory: identifying progress and disparities for Aboriginal peoples, 1991-2020.

Improved cancer survival in the Northern Territory: identifying progress and disparities for Aboriginal peoples, 1991-2020.

Journal: The Medical journal of Australia

Published: May 29, 2024

Real-world experience of immune checkpoint inhibitors in patients with solid tumours in the Top End of the Northern Territory, Australia from 2016 to 2021: a retrospective observational cohort study.

Real-world experience of immune checkpoint inhibitors in patients with solid tumours in the Top End of the Northern Territory, Australia from 2016 to 2021: a retrospective observational cohort study.

Journal: Internal medicine journal

Published: March 13, 2024

Significance of lung nodules detected on chest CT among adult Aboriginal Australians - a retrospective descriptive study.

Significance of lung nodules detected on chest CT among adult Aboriginal Australians - a retrospective descriptive study.

Journal: Journal of medical radiation sciences

Published: November 21, 2023

Breast cancer characteristics and pathological prognostic determinants in indigenous Australians: Retrospective cohort study in the Northern Territory.

Breast cancer characteristics and pathological prognostic determinants in indigenous Australians: Retrospective cohort study in the Northern Territory.

Journal: Asia-Pacific journal of clinical oncology

Published: July 07, 2022

Bilateral facial nerve palsy associated with amphiphysin antibody in metastatic breast cancer: a case report.

Bilateral facial nerve palsy associated with amphiphysin antibody in metastatic breast cancer: a case report.

Journal: Journal of medical case reports

Published: June 28, 2020

Thymic hyperplasia following double immune checkpoint inhibitor therapy in two patients with stage IV melanoma.

Thymic hyperplasia following double immune checkpoint inhibitor therapy in two patients with stage IV melanoma.

Journal: Asia-Pacific journal of clinical oncology

Published: January 12, 2019

Pembrolizumab for metastatic melanoma in a renal allograft recipient with subsequent graft rejection and treatment response failure: a case report.

Pembrolizumab for metastatic melanoma in a renal allograft recipient with subsequent graft rejection and treatment response failure: a case report.

Journal: Journal of medical case reports

Published: September 05, 2016

Targeting MET and EGFR in NSCLC-what can we learn from the recently reported phase III trial of onartuzumab in combination with erlotinib in advanced non-small cell lung cancer?

Targeting MET and EGFR in NSCLC-what can we learn from the recently reported phase III trial of onartuzumab in combination with erlotinib in advanced non-small cell lung cancer?

Journal: Translational lung cancer research

Published: September 03, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026